Literature DB >> 8331718

Cytotoxic effects of topical antimicrobial and antiseptic agents on human keratinocytes in vitro.

R G Teepe1, E J Koebrugge, C W Löwik, P L Petit, R W Bosboom, I M Twiss, H Boxma, B J Vermeer, M Ponec.   

Abstract

The cytotoxicity of commonly used antimicrobial and antiseptic agents to cultured human keratinocytes was investigated, combining a morphologic assay with a quantitative neutral red (NR) spectrophotometric assay. Main outcome criteria of response were the initial cytotoxicity (NR 90) and midpoint cytotoxicity (NR 50) and the highest tolerated dose (HTD), a concentration causing the first observed morphologic alterations. These values were compared with commonly administered clinical doses or calculated doses. Thirty-five agents were evaluated; five agents were also subjected to an assay for cell morphologic alterations, and HTD and percentage of cells taking up trypan blue and annihilation dose were assessed. These studies show that in clinical concentrations many, but not all, agents exert profound cytotoxic effects. The results suggest that under certain conditions cultured epithelial grafts may be exposed to clinical concentrations of neomycin, clindamycin, framycetin, erythromycin, gentamicin, and 0.1% solutions of povidone-iodine. Tetrachlorodecaoxygen anion complex (TCDO) should be further evaluated as a likely effective cleansing agent before culture grafting.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331718     DOI: 10.1097/00005373-199307000-00002

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  12 in total

1.  Photodynamic inactivation of fibroblasts by a cationic porphyrin.

Authors:  Saskia A G Lambrechts; Kevin R Schwartz; Maurice C G Aalders; Jacob B Dankert
Journal:  Lasers Med Sci       Date:  2005-06-07       Impact factor: 3.161

2.  Redo total aortic arch replacement using an extended homograft for graft infection.

Authors:  Shinichi Sato; Yoshikatsu Saiki; Yoshio Nitta; Katsuhiko Oda; Goro Takahashi; Koichi Tabayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-10

3.  Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS.

Authors:  S P Raffanti; W Schaffner; C F Federspiel; R B Blackwell; O A Ching; F W Kühne
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

4.  The sterilization of honey with cobalt 60 gamma radiation: a study of honey spiked with spores of Clostridium botulinum and Bacillus subtilis.

Authors:  T Postmes; A E van den Bogaard; M Hazen
Journal:  Experientia       Date:  1995-09-29

5.  The Bactericidal And Cytotoxic Effects Of Antimicrobial Wound Cleansers.

Authors:  Vicki S Rabenberg; Christopher D Ingersoll; Michelle A Sandrey; Mary T Johnson
Journal:  J Athl Train       Date:  2002-03       Impact factor: 2.860

6.  [Treatment of MRSA infection in orthopedic surgery].

Authors:  Th Mückley; Ch Hierholzer; M Diefenbeck; G O Hofmann; V Bühren
Journal:  Chirurg       Date:  2004-03       Impact factor: 0.955

7.  In vitro comparison of chlorhexidine and povidone-iodine on the long-term proliferation and functional activity of human alveolar bone cells.

Authors:  Cristina Trigo Cabral; Maria Helena Fernandes
Journal:  Clin Oral Investig       Date:  2007-01-11       Impact factor: 3.606

8.  Topical treatment for facial burns.

Authors:  Cornelis J Hoogewerf; M Jenda Hop; Marianne K Nieuwenhuis; Irma Mmh Oen; Esther Middelkoop; Margriet E Van Baar
Journal:  Cochrane Database Syst Rev       Date:  2020-07-29

Review 9.  Exploitation of cytotoxicity of some essential oils for translation in cancer therapy.

Authors:  Rossella Russo; Maria Tiziana Corasaniti; Giacinto Bagetta; Luigi Antonio Morrone
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-04       Impact factor: 2.629

10.  A Comparison Study of Growth Factor Expression following Treatment with Transcutaneous Electrical Nerve Stimulation, Saline Solution, Povidone-Iodine, and Lavender Oil in Wounds Healing.

Authors:  Adalet Koca Kutlu; Dilek Ceçen; Seren Gülşen Gürgen; Oya Sayın; Ferihan Cetin
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.